It will be less of the 'finding a perfect patient' and more of the rather impressive list of exclusion criteria, and the fact that at a unit like Duke there will be a variety of trials competing for the not so uncommon G1 treatment failure (who by their having experienced prior treatment are generally patients who are usually excellent candidates for clinical trials).
- Forums
- ASX - By Stock
- BLT
- tt-034 first dose
tt-034 first dose, page-8
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)